COVID-19
COVID-19 Articles
A growing number of scientists believe that the increase in daily deaths due to COVID-19 in America is not over.
Published:
Summer blockbusters may have to wait a little longer to hit theaters now that the world’s largest movie-theater chain announced that it would further delay its reopening.
Published:
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
Published:
Anyone who has walked by or driven past strip malls knows that many of the businesses there are closed down during the COVID-19 pandemic. What may not be as obvious is just how many of those...
Published:
In the e-commerce era, when brick-and-mortar retailers by and large are failing, Best Buy is making a name for itself.
Published:
Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in the meantime, these companies will get a nice payoff.
Published:
Last Updated:
Amazon.com is pushing back its much-lauded Prime Day due to the pandemic. Will this cause near-term pain for investors?
Published:
There are no assurances that this stock will keep rising after such a rapid rise, but many investors with a long-term view now likely will view any pullbacks as opportunities to buy the stock.
Published:
BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than 160% year to date, it’s time to capitalize.
Published:
Last Updated:
Moleculin Biotech joins the ever-expanding list of coronavirus stocks as the company announced that a second round of independent laboratory testing has confirmed the antiviral activity of WP1122.
Published:
Immuron continued its winning streak on Tuesday after the company announced that its IMM-124E has demonstrated neutralizing activity against the severe acute respiratory syndrome due to the virus...
Published:
While the United States considers its COVID-19 spread with horror, two much smaller nations have suffered tremendously as well.
Published:
Sorrento Therapeutics has announced that its treatment for COVID-19 had cleared its Phase 2 study in hospitalized patients with moderate to severe coronavirus infections.
Published:
Analysts have been tripping all over themselves chasing Amazon higher for quite a while. A couple more analysts have come out with new higher price targets for the e-commerce empire.
Published:
GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.
Published: